Peptides: A No-BS Primer

The first time I read about BPC-157, I thought I had stumbled onto something miraculous. Every forum post described it the same way: “I was injured for months, started BPC-157, healed in two weeks.” The actual literature, when I finally got around to reading it, was almost entirely rats. Rats with surgically induced tendon damage in controlled lab settings. Almost zero placebo-controlled human trials. That gap between forum confidence and published evidence is the entire problem with how peptides get talked about online.

This article is the version I wish I had read first. What peptides are, what the evidence does and does not support, and why the regulatory landscape opened back up.

What peptides are

Peptides are short chains of amino acids. Proteins are long chains of amino acids. The difference is mostly size. A peptide might be 10 to 50 amino acids long. A protein might be hundreds or thousands. The body uses peptides as signaling molecules: they bind to specific receptors on cell surfaces and trigger downstream responses. Insulin is a peptide. Growth hormone is technically a peptide. Glucagon is a peptide. The body makes thousands of them and uses them constantly.

When people talk about “peptide therapy,” they are usually talking about exogenous peptides administered by injection (subcutaneous in most cases) to mimic, replace, or amplify a natural signaling pathway. Peptides are not steroids. They are not anabolic in the traditional bodybuilding sense. They do not work the same way TRT does. Most of them do not get you “bigger.” That is not what they are for.

The deeper mechanisms are in the peptides wiki. This article stays at the conceptual level so you can decide whether to go further.

The categories that matter

There are dozens of peptides being discussed online and most of them don’t matter. The categories worth knowing about are these:

Healing peptides. BPC-157 and TB-500 are the famous ones. Marketed for tendon, ligament, and gut repair. The evidence is mostly rats. Not zero human evidence, but thin enough that anyone selling these to you should be saying “the literature is mostly preclinical” out loud. They might work in humans. They might not. The honest answer right now is that we don’t know with confidence.

GH secretagogues. Sermorelin, CJC-1295, Ipamorelin, Tesamorelin. These don’t replace growth hormone. They stimulate your pituitary to make more of its own. The advantage over straight GH is that they preserve the pulsatile rhythm the body uses, which is gentler on the system and avoids some of the long-term issues with exogenous GH. The evidence is decent in humans for body composition, sleep quality, and recovery. These are the boring middle of the peptide world and probably the most useful for most men.

GLP-1 peptides. Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the newer compounds. The strongest human evidence of any peptide class. Originally developed for diabetes, then weight loss, now being studied for cardiovascular outcomes, Alzheimer’s, addiction, and more. If you only know one peptide class, this is probably the one to know.

Melanotan and other niche stuff. I am not going to get into these. They are riskier, the evidence is thinner, and they are not in the canon for what most men reading this should care about.

What the evidence says

Here is the honest version of where the evidence sits, ranked from strongest to weakest:

1. GLP-1 peptides. Strong human RCT evidence. FDA approved for multiple conditions. Probably the most evidence-backed peptide therapy in existence right now.
2. GH secretagogues. Moderate human evidence. Studied for decades. Used clinically for HIV-related lipodystrophy (Tesamorelin) and growth hormone deficiency. Off-label use in healthy adults for body composition and recovery is supported by smaller studies and a lot of clinical experience.
3. BPC-157 and TB-500. Mostly preclinical. Strong rat data. Promising mechanism. Real human trials are sparse and small. Most of the human evidence is anecdotal forum reports, which is not nothing but is not the same as a clinical trial.
4. Everything else. Variable. Read the actual papers before you spend money.

This is not an argument for not trying any of these. It is an argument for knowing what you are buying when you do. “I’m trying BPC-157 because the rat studies look promising and the safety profile in those studies is reassuring” is a defensible position. “BPC-157 is proven to heal tendons in humans” is not.

The 2026 regulatory shift

In February 2026, HHS reversed parts of the 2023 FDA decision that had restricted compounding pharmacies from formulating 14 specific peptides. That restriction had cut off legal access for thousands of patients who were getting peptides through compounding pharmacies under their doctor’s supervision. The reversal restored that access and signaled, at least for now, that the federal posture toward peptide compounding has shifted.

This matters practically because compounding is the main way patients get peptides legally and affordably in the United States. The brand-name pharma versions exist for a few peptides (Tesamorelin as Egrifta, semaglutide as Ozempic) but they are expensive and gatekept. Compounded versions through a 503A pharmacy are typically 5 to 10 times cheaper and accessible through telehealth providers. The 2026 reversal kept that pipeline open.

I am reporting this factually. I am not making it a political story. The compounding wiki has the longer regulatory timeline if you want it.

What I do

I have used Sermorelin in cycles for sleep and recovery. I noticed deeper sleep within about ten days and stuck with it for a few months. I have not used BPC-157 because I have not had an injury that warranted experimenting with something that thin on human evidence. I have not used GLP-1s because I do not currently have a use case for them. None of that is a recommendation. It is one data point.

The mistake I see most often: men buying peptide stacks off Instagram from gray-market vendors. The peptide quality from those sources is unverifiable, the contamination risk is real, and you lose the only adult in the room (a compounding pharmacy with quality control) when you go that route. If you are going to try peptides, do it through a real provider and a real pharmacy. The savings from buying gray-market are not worth the risk.

The point

Peptides are not magic and they are not snake oil. They are a real category of therapeutic agents with wildly variable evidence quality across the category. The class with the strongest evidence (GLP-1) gets called “weight loss drugs.” The class with the weakest evidence (healing peptides) gets called “miracle compounds” by the people selling them. Both descriptions are wrong. Read the literature. Talk to a real provider. Ignore the Instagram vendors.

If you want to understand the access pipeline these peptides flow through, the next stop is compounding pharmacies, which is a more interesting topic than it sounds: Compounding Pharmacies: What They Are and Why They Matter.